Posted in | News | Remote Monitoring

Renal Ventures Management Selects Authentidate's Telehealth Solution

Authentidate Holding Corp., a provider of web-based revenue cycle management applications and telehealth products and services for healthcare organizations, announced today that Renal Ventures Management, LLC (RVM), a leading provider of dialysis services for patients suffering from chronic kidney failure, selected Authentidate's telehealth solution for the remote monitoring of some of the dialysis patients who have kidney failure. The roll out is expected to begin in the third quarter of 2015.

In 2012, there were more than 20 million people in the United States (10% of the population) with some level of Chronic Kidney Disease (CKD) according to the Centers for Disease Control and Prevention. RVM serves CKD patients through their network of dialysis centers, which include 35 dialysis partnerships and 26 inpatient service contracts across the U.S. While RVM patients' overall quality scores are better than national averages, RVM's goal is to continue to improve those quality scores and Authentidate's solutions will be integral to this enhancement.

Authentidate's Telehealth Solution is designed to help patients achieve their goals to get healthy and stay healthy with an easy to use mobile device that captures vital signs, symptoms, and treatment plan compliance in the home and shares the associated data in real time with the patient's care givers via the internet.

RVM Chief Medical Officer George R. Aronoff, MD, MS, FACP, commented, "Patients with kidney failure are at high risk during the first four months of starting dialysis treatments. We are enthusiastic about using Authentidate telehealth services for health informatics, disease management and remote monitoring technologies to enhance care and case management for our most vulnerable patients. At Renal Ventures Management, we believe that home monitoring using telehealth technology provides an innovative tool for our patients and care givers to improve wellness and quality of life."

The RVM application is another excellent use case for Authentidate's proven and innovative solution for remote patient management and aligns with the company's focus on improving quality of care and reducing the cost of care. RVM remains committed to meeting the increasing demand in the market for flexible and effective remote patient management.

"Authentidate's remote patient management solutions have helped thousands of patients across the commercial and government healthcare sectors, and our recent innovations are powerful tools in patient care. We're excited about RVM's thought leadership and are proud of the support our solutions bring to the RVM team as they have a positive impact on their patients' lives," said Ian Bonnet, President and CEO of Authentidate.

Mr. Bonnet added, "The dialysis segment is a niche where our solutions can have a positive impact and an extension of our proven disease management protocols. This agreement calls for RVM to purchase both our proprietary telehealth devices and associated software subscriptions for the benefit of their patients. The agreement was reached as an outcome of the renewed focus and strategy we have at Authentidate. We are working on partnering with other industry leaders like RVM and hope to be able to announce additional contracts in the future."

Source: http://www.authentidate.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.